The efficacy of the mentioned Covid-19 Sinovac vaccine is not known its efficacy, is it harmful to continue? All pages

KOMPAS.com – Sinovac Biotech Ltd has provided the latest statement on the efficacy of the company’s coronavirus vaccine.

This statement was provided in response to a statement from PT Bio Farma that stated that the effectiveness of the vaccine reached 97 percent in initial clinical trials.

However, Bio Farma later clarified this matter.

Also read: Get to know the Sinovac vaccine that has arrived in Indonesia

The spokesperson for Sinovac Biotech Ltd said the efficacy of the vaccine is not known so far.

Launching Bloomberg, Tuesday (8/12/2020), according to Sinovac, the 97 percent figure refers to the seroconversion rate that is separate from the efficacy of the vaccine.

The reason is that the high seroconversion rate does not mean that the vaccine is effective in protecting people from the corona virus.

Also read: Judging by the comparison of Pfizer’s Corona vaccine to Sinovac, what are you?

So is this vaccine dangerous if it is continued?

I’m not sure yet

The epidemiologist at the Faculty of Public Health at the University of Indonesia (FKM UI) Pandu Riono said the safety and efficacy of the Sinovac vaccine cannot be determined.

It follows that the third phase of the clinical trial of the vaccine is still underway and approval from the Food and Drug Supervision Agency (BPOM) has not been issued.

Also read: Apart from the UK, these are the countries that have allowed the use of the Pfizer Covid-19 vaccine

Therefore, Pandu warned the government and the public not to be lulled into the euphoria of this corona virus vaccine.

“Because the study has not been completed, I am also not aware of the side effects of this vaccine. issue this is the biggest one, “Pandu said when contacted Kompas.com, Friday (11/12/2020).

On the one hand, Pandu, who from the beginning criticized the government for the purchase of vaccines, returned his criticism.

Also read: Here are 13 diseases that have been successfully treated with vaccines, what are they?

The government had the wrong strategy

PHOTOS ANTARA / DHEMAS REVIYANTO Officers check containers containing COVID-19 vaccine when they arrive at Soekarno-Hatta Airport, Tangerang, Banten, on Sunday (6/12/2020). Up to 1.2 million doses of the COVID-19 vaccine manufactured by the pharmaceutical company Sinovac, China, arrived in Indonesia for further processing at Bio Farma as a state-owned vaccine producer.

Pandu assessed that since the beginning of the corona virus pandemic that affected Indonesia, the government had made a mistake in executing the strategy.

“I think the government has a wrong strategy, it believes that the vaccine is the best solution. The vaccine is secondary prevention (second prevention) temporarily Primary prevention(main prevention) is still a disaster, “Pandu said.

“Yes, in my opinion it seems not deal-deal efficiency, but purely business, “he added.

Also read: Questioning Pertamina and her children’s business

On top of that, Pandu continued, acquiring this vaccine is like buying a cat in a sack.

And this criticism has haunted him for a long time, but, he said, no one has grasped what he means.

“So yes, we will continue to monitor what happens next,” Pandu said.

Also read: 5 things about the Sinovac vaccine that are known so far

Wait for a decision from BPOM

Windhu Purnomo, an epidemiologist at Airlangga (Unair) Surabaya University, expressed a similar opinion.

It assessed whether the Sinovac vaccine was safe or not, of course, it had to be seen from the data from the phase 3 clinical trial that was currently underway and the decision of the BPOM.

“So then we will wait for BPOM, the BPOM will test its feasibility in terms of efficacy and safety after looking at the scientific evidence,” Windhu told Kompas.com, Friday (11/12/2020).

Also read: Crowded talk, Is the use of convalescent plasma therapy effective for Covid-19 patients?

Therefore, Windhu cannot explain in more detail whether the Sinovac vaccine is dangerous or safe if it is continued.

“To this day, what has been tested in Unpad has had no reports of unexpected events, it has never turned up. But the trial has not been completed. Now when I was asked if the vaccine is safe or not, I don’t I know because of the rehearsal. It’s not over yet, “he explained.

Also read: Fighting the third wave of Covid-19, South Korea builds a hospital from containers